Which is more useful in non-obese patients (BMI<30) undergoing tracheal intubation, T1% of the corrugator supercilii muscle, or effect site concentration of rocuronium calculated by the iPad application AnestAssist ?

UMIN ID: UMIN000012431

Registered date:28/11/2013

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Diseases which require elective surgery under general anesthesia
• Date of first enrollment: 2013/11/29
• Target sample size: 165
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Patients who are given rocuronium 0.6mg/kg before tracheal intubation
Patients who are given rocuronium 0.7mg/kg before tracheal intubation
Patients who are given rocuronium 0.8mg/kg before tracheal intubation
Patients who are given rocuronium 0.9mg/kg before tracheal intubation
Patients who are given rocuronium 1.0mg/kg before tracheal intubation
Patients who are given rocuronium 1.1mg/kg before tracheal intubation
Patients who are given rocuronium 1.2mg/kg before tracheal intubation

Outcome(s)

• Primary Outcome: T1% of the corrugator supercilii muscle, effect site concentration of rocurronium calculated by software, and tracheal intubation condition
• Secondary Outcome: What patient characteristics affect tracheal intubation condition?

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: 90years-old
• Gender: Male and Female
• Exclude criteria: 1. When it is difficult to intubate, the patient is excluded. 2. When it is impossible to calibrate TOF-Watch, the patient is excluded. 3. When unexpected complications occur, the patient is excluded.

Related Information

• Primary Sponsor: Department of Anesthesiology, Keiyu Hospital
• Source(s) of Monetary Support: None